|
|
|
|
|
30.10.26 - 09:45
|
Results: AstraZeneca 3Q Revenue Up 7%; Profit Beats (AAStocks)
|
|
|
AstraZeneca (AZN.US) logged a 7% increase in 3Q revenue to USD16.209 billion, while core EPS reached USD2.79, beating expectations, driven by stronger-than-expected sales of blockbuster cancer drugs including Imfinzi and Tagrisso. Sales of Tagrisso, AstraZeneca's best-selling cancer drug, amounted to USD2.09 billion during t......
|
|
|
|
|
30.10.26 - 08:57
|
Astrazeneca legt stärker zu als gedacht (DPA-AFX)
|
|
|
LONDON (dpa-AFX) - Der Erfolg von Krebsmedikamenten hat dem Pharmakonzern AstraZeneca auch im dritten Quartal überraschend deutliche Zuwächse beschert. Der Umsatz wuchs im Jahresvergleich um sieben Prozent auf rund ......
|
|
|
|
|
|
|
|
|
|
|
|
|
29.10.26 - 12:06
|
Veeva Summit Showcases AI and Data Innovations Advancing Agentic Commercial (PR Newswire)
|
|
|
AstraZeneca, Bristol Myers Squibb, Grünenthal, Novo, Roche, UCB and more to showcase new approaches for connected customer engagement, agentic MLR, and medical impact BARCELONA, Spain, Oct. 29, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that leaders from AstraZeneca,......
|
|
|
|
|
28.10.26 - 11:24
|
AstraZeneca Hold (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca mit einem Kursziel von 11700 Pence auf "Hold" belassen. Nach der schwächeren US-Onkologiekonferenz Asco hätten die Briten bei der Jahrestagung des europäischen Pendants ......
|
|
|
|
|
27.10.26 - 19:45
|
Breast Cancer Canada and AstraZeneca Canada Advance Next-Generation Survivorship Research (Business Wire)
|
|
|
Announced at ESMO 2026: $200,000 in matched funding to advance the future of Canadian breast cancer survivorship.TORONTO--(BUSINESS WIRE)--Breast Cancer Canada and AstraZeneca Canada are investing $200,000 in matched research funding to address critical gaps in breast cancer survivorship and improve care for Canadians living with and beyond the disease. Announced at Breast Cancer Canada's Canadian Night reception during the European Society for Medical Oncology (ESMO) Congress in Madrid, the funding will support two Canadian research initiatives, each receiving $100,000 to advance innovative approaches to patient navigation, survivorship research and personalized care.
Through this partnership, Breast Cancer Canada and AstraZeneca Canada are advancing research and innovation to address critical gaps across the survivorship continuum. The funded projects will explore digital health and artificial intelligence (AI) approaches to strengthen patient navigation, better understand patient needs, and inform mor...
|
|
|
|
|
|
|
|
|
27.10.26 - 13:01
|
Astrazeneca′s Enhertu secures EU approval (ShareCast)
|
|
|
Drugmaker Astrazeneca said on Tuesday that Enhertu has been approved in the European Union as an adjuvant treatment for adults with HER2‑positive early breast cancer who still have signs of invasive disease after initial chemotherapy...
|
|
|
27.10.26 - 11:33
|
AstraZeneca Buy (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Astrazeneca anlässlich der Jahrestagung der Europäischen Gesellschaft für Medizinische Onkologie (Esmo) auf "Buy" mit einem Kursziel von 17500 Pence belassen. Die Veranstaltung ......
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
